| scholarly article | Q13442814 |
| P2093 | author name string | B König | |
| W König | |||
| F Layer | |||
| I Tammer | |||
| J Färber | |||
| K-A Moder | |||
| P2860 | cites work | Validation of VITEK 2 version 4.01 software for detection, identification, and classification of glycopeptide-resistant enterococci | Q43186672 |
| Evaluation of the Phoenix 100 ID/AST system and NID panel for identification of Enterobacteriaceae, Vibrionaceae, and commonly isolated nonenteric gram-negative bacilli | Q43234683 | ||
| International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections | Q43699184 | ||
| Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3. | Q44235785 | ||
| Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection | Q44901126 | ||
| Comparative evaluation of the VITEK 2 Advanced Expert System (AES) in five UK hospitals | Q47971500 | ||
| CTX-M: changing the face of ESBLs in the UK. | Q53851440 | ||
| Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates. | Q53941913 | ||
| Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital | Q73239627 | ||
| Comparative evaluation of a new Vitek 2 system for identification and antimicrobial susceptibility testing of Streptococcus pneumoniae | Q82315203 | ||
| Extended-spectrum beta-lactamases: a clinical update | Q24534999 | ||
| Extended-spectrum beta-lactamases and clinical outcomes: current data | Q33236875 | ||
| Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. | Q33690464 | ||
| Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. | Q33972587 | ||
| Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci | Q34193386 | ||
| Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. | Q34201311 | ||
| Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens | Q34708485 | ||
| Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method | Q34974437 | ||
| Two-center collaborative evaluation of performance of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria | Q35220822 | ||
| CTX-M: changing the face of ESBLs in Europe | Q36678524 | ||
| Management of multidrug-resistant organisms in health care settings, 2006. | Q37027940 | ||
| Chromosomally encoded ampC-type beta-lactamase in a clinical isolate of Proteus mirabilis | Q39558426 | ||
| Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. | Q39664817 | ||
| Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex | Q39665321 | ||
| Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases | Q41939169 | ||
| Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp. | Q42130010 | ||
| Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures | Q42799124 | ||
| Evaluation of a new selective chromogenic agar medium for detection of extended-spectrum beta-lactamase-producing Enterobacteriaceae | Q42912527 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | automation | Q184199 |
| P304 | page(s) | 3721-3727 | |
| P577 | publication date | 2008-09-24 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium | |
| P478 | volume | 46 |
| Q41866259 | Colorimetric-plate method for rapid disk diffusion susceptibility testing of Escherichia coli. |
| Q27026063 | Current trends in culture-based and molecular detection of extended-spectrum-β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae |
| Q41016317 | Evaluation of Brilliance ESBL agar, a novel chromogenic medium for detection of extended-spectrum-beta- lactamase-producing Enterobacteriaceae. |
| Q54369631 | Evaluation of the VITEK 2 AST-N111 card for detection of extended-spectrum beta-lactamases (ESBLs) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca compared to ESBL Etests and combination disk methods. |
| Q35090146 | Expert systems in clinical microbiology |
| Q37420296 | Extended Spectrum beta-Lactamases among Gram-Negative Bacterial Isolates from Clinical Specimens in Three Major Hospitals in Northern Jordan |
| Q30847357 | Impact of minimal inhibitory concentration breakpoints on local cumulative bacterial susceptibility data and antibiotic consumption |
| Q36358424 | Molecular Epidemiology of ESBL Genes and Multi-Drug Resistance in Diarrheagenic Escherichia Coli Strains Isolated from Adults in Iran |
| Q35868674 | Rectal Carriage of Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Selective Preenrichment Increases Yield of Screening. |
Search more.